BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 19224502)

  • 21. Fracture-induced changes in biomarkers CTX, PINP, OC, and BAP-a systematic review.
    Højsager FD; Rand MS; Pedersen SB; Nissen N; Jørgensen NR
    Osteoporos Int; 2019 Dec; 30(12):2381-2389. PubMed ID: 31446441
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Investigation on bone health conditions in 1637 aged women].
    Li HL; Zhu HM; Cheng Q; Du YP; Hong W; Zhu XY; Zhang XM; Xue SH; Gan JM
    Zhonghua Fu Chan Ke Za Zhi; 2011 Jul; 46(7):492-5. PubMed ID: 22041439
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biochemical bone turnover markers in hormonal disorders in adults: a narrative review.
    Szulc P
    J Endocrinol Invest; 2020 Oct; 43(10):1409-1427. PubMed ID: 32335857
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estrogen-dependent increase in bone turnover and bone loss in postmenopausal women with breast cancer treated with anastrozole. Prevention with bisphosphonates.
    Confavreux CB; Fontana A; Guastalla JP; Munoz F; Brun J; Delmas PD
    Bone; 2007 Sep; 41(3):346-52. PubMed ID: 17618847
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Direct comparison of eight national FRAX® tools for fracture prediction and treatment qualification in Canadian women.
    Leslie WD; Brennan SL; Lix LM; Johansson H; Oden A; McCloskey E; Kanis JA
    Arch Osteoporos; 2013; 8():145. PubMed ID: 23929269
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of denosumab on bone turnover markers in postmenopausal osteoporosis.
    Eastell R; Christiansen C; Grauer A; Kutilek S; Libanati C; McClung MR; Reid IR; Resch H; Siris E; Uebelhart D; Wang A; Weryha G; Cummings SR
    J Bone Miner Res; 2011 Mar; 26(3):530-7. PubMed ID: 20839290
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ten-year probability of osteoporotic fracture in 2012 Polish women assessed by FRAX and nomogram by Nguyen et al.-Conformity between methods and their clinical utility.
    Pluskiewicz W; Adamczyk P; Franek E; Leszczynski P; Sewerynek E; Wichrowska H; Napiorkowska L; Kostyk T; Stuss M; Stepien-Klos W; Golba KS; Drozdzowska B
    Bone; 2010 Jun; 46(6):1661-7. PubMed ID: 20156606
    [TBL] [Abstract][Full Text] [Related]  

  • 28. WHO fracture risk calculator (FRAX) in the assessment of obese patients with osteoporosis.
    Franek E; Wichrowska H; Gozdowski D; Puzianowska-Kuźnicka M
    Endokrynol Pol; 2009; 60(2):82-7. PubMed ID: 19396750
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Fracture Risk Assessment Tool (FRAX®): applications in clinical practice.
    Watts NB
    J Womens Health (Larchmt); 2011 Apr; 20(4):525-31. PubMed ID: 21438699
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of yearly zoledronic acid 5 mg on bone turnover markers and relation of PINP with fracture reduction in postmenopausal women with osteoporosis.
    Delmas PD; Munoz F; Black DM; Cosman F; Boonen S; Watts NB; Kendler D; Eriksen EF; Mesenbrink PG; Eastell R;
    J Bone Miner Res; 2009 Sep; 24(9):1544-51. PubMed ID: 19338427
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Real-world bone turnover marker use: impact on treatment decisions and fracture.
    Lane NE; Saag K; O'Neill TJ; Manion M; Shah R; Klause U; Eastell R
    Osteoporos Int; 2021 May; 32(5):831-840. PubMed ID: 33236195
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pretreatment levels of bone turnover and the antifracture efficacy of alendronate: the fracture intervention trial.
    Bauer DC; Garnero P; Hochberg MC; Santora A; Delmas P; Ewing SK; Black DM;
    J Bone Miner Res; 2006 Feb; 21(2):292-9. PubMed ID: 16418785
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bone mineral density, bone turnover markers and fractures in patients with indolent systemic mastocytosis.
    Rossini M; Zanotti R; Bonadonna P; Artuso A; Caruso B; Schena D; Vecchiato D; Bonifacio M; Viapiana O; Gatti D; Senna G; Riccio A; Passalacqua G; Pizzolo G; Adami S
    Bone; 2011 Oct; 49(4):880-5. PubMed ID: 21782049
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of biochemical markers of bone metabolism in relation to the occurrence of fracture: a retrospective and prospective population-based study of women.
    Akesson K; Ljunghall S; Jonsson B; Sernbo I; Johnell O; Gärdsell P; Obrant KJ
    J Bone Miner Res; 1995 Nov; 10(11):1823-9. PubMed ID: 8592961
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence-based guidelines for the use of biochemical markers of bone turnover in the selection and monitoring of bisphosphonate treatment in osteoporosis: a consensus document of the Belgian Bone Club.
    Bergmann P; Body JJ; Boonen S; Boutsen Y; Devogelaer JP; Goemaere S; Kaufman JM; Reginster JY; Gangji V;
    Int J Clin Pract; 2009 Jan; 63(1):19-26. PubMed ID: 19125989
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of bone turnover markers with volumetric bone loss, periosteal apposition, and fracture risk in older men and women: the AGES-Reykjavik longitudinal study.
    Marques EA; Gudnason V; Lang T; Sigurdsson G; Sigurdsson S; Aspelund T; Siggeirsdottir K; Launer L; Eiriksdottir G; Harris TB
    Osteoporos Int; 2016 Dec; 27(12):3485-3494. PubMed ID: 27341810
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Osteoporosis - whom to treat? The importance of FRAX® in Switzerland].
    Lippuner K
    Ther Umsch; 2012 Mar; 69(3):207-13. PubMed ID: 22403115
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of calcitriol or calcium on bone mineral density, bone turnover, and fractures in men with primary osteoporosis: a two-year randomized, double blind, double placebo study.
    Ebeling PR; Wark JD; Yeung S; Poon C; Salehi N; Nicholson GC; Kotowicz MA
    J Clin Endocrinol Metab; 2001 Sep; 86(9):4098-103. PubMed ID: 11549632
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hip and nonvertebral fracture prediction in nursing home patients: role of bone ultrasound and bone marker measurements.
    Dobnig H; Piswanger-Sölkner JC; Obermayer-Pietsch B; Tiran A; Strele A; Maier E; Maritschnegg P; Riedmüller G; Brueck C; Fahrleitner-Pammer A
    J Clin Endocrinol Metab; 2007 May; 92(5):1678-86. PubMed ID: 17311861
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women?
    Chavassieux P; Portero-Muzy N; Roux JP; Garnero P; Chapurlat R
    J Clin Endocrinol Metab; 2015 Dec; 100(12):4662-8. PubMed ID: 26505821
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.